Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Nejat, RJ; Purohit, R; Goluboff, ET; Petrylak, D; Rubin, MA; Benson, MC
   Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy
   UROLOGIC ONCOLOGY
   
   R.J. Nejat et al., "Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy", UROL ONCOL, 6(2), 2001, pp. 53-55
2. Small, EJ; Figlin, R; Petrylak, D; Vaughn, DJ; Sartor, O; Horak, I; Pincus, R; Kremer, A; Bowden, C
   A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma
   INVESTIGATIONAL NEW DRUGS
   
   E.J. Small et al., "A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma", INV NEW DR, 18(2), 2000, pp. 193-197
3. Kreis, W; Petrylak, D; Savarese, D; Budman, D
   Colitis and docetaxel-based chemotherapy
   LANCET
   
   W. Kreis et al., "Colitis and docetaxel-based chemotherapy", LANCET, 355(9221), 2000, pp. 2164-2164
4. Hussain, M; Petrylak, D; Fisher, E; Tangen, C; Crawford, D
   Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: Scientific basis and design of Southwest Oncology Group study 9916
   SEMINARS IN ONCOLOGY
   
   M. Hussain et al., "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: Scientific basis and design of Southwest Oncology Group study 9916", SEMIN ONCOL, 26(5), 1999, pp. 55-60
5. SAWCZUK I; PETRYLAK D; BENEDETTO P; BERRIS R; BUKOWSKI R; DREICER R; EINSTEIN A; ELLERHORST J; GOODMAN G; GRAHAM S; HARRIS D; KEMPF R; KLAMET J; KUZEL T; LEONG S; LOGAN T; MEYERS F; MILLER W; MURPHY B; MCCAFFREY R; WALTHER P; WILLIAMS D; HAWKINS M
   RANDOMIZED, CONTROLLED TRIAL OF EX-VIVO ACTIVATED T-CELLS VS. INTERFERON-ALPHA IN METASTATIC RENAL-CANCER
   The Journal of urology
   
   I. Sawczuk et al., "RANDOMIZED, CONTROLLED TRIAL OF EX-VIVO ACTIVATED T-CELLS VS. INTERFERON-ALPHA IN METASTATIC RENAL-CANCER", The Journal of urology, 159(5), 1998, pp. 740-740
6. WRIGHT GL; GROB BM; HALEY C; GROSSMAN K; NEWHALL K; PETRYLAK D; TROYER J; KONCHUBA A; SCHELLHAMMER PF; MORIARTY R
   UP-REGULATION OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN AFTER ANDROGEN-DEPRIVATION THERAPY
   Urology
   
   G.L. Wright et al., "UP-REGULATION OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN AFTER ANDROGEN-DEPRIVATION THERAPY", Urology, 48(2), 1996, pp. 326-334
7. SCHER HI; SARKIS A; REUTER V; COHEN D; NETTO G; PETRYLAK D; LIANES P; FUKS Z; MENDELSOHN J; CORDONCARDO C
   CHANGING PATTERN OF EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA IN THE PROGRESSION OF PROSTATICNEOPLASMS
   Clinical cancer research
   
   H.I. Scher et al., "CHANGING PATTERN OF EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA IN THE PROGRESSION OF PROSTATICNEOPLASMS", Clinical cancer research, 1(5), 1995, pp. 545-550
8. KHALED Z; RIDEOUT D; ODRISCOLL KR; PETRYLAK D; CACACE A; PATEL R; CHIANG LC; ROTENBERG S; STEIN CA
   EFFECTS OF SURAMIN-RELATED AND OTHER CLINICALLY THERAPEUTIC POLYANIONS ON PROTEIN-KINASE-C ACTIVITY
   Clinical cancer research
   
   Z. Khaled et al., "EFFECTS OF SURAMIN-RELATED AND OTHER CLINICALLY THERAPEUTIC POLYANIONS ON PROTEIN-KINASE-C ACTIVITY", Clinical cancer research, 1(1), 1995, pp. 113-122
9. NAIK HR; PETRYLAK D; YAGODA A; LEHR JE; AKHTAR A; PIENTA KJ
   PRECLINICAL STUDIES OF GOSSYPOL IN PROSTATE CARCINOMA
   International journal of oncology
   
   H.R. Naik et al., "PRECLINICAL STUDIES OF GOSSYPOL IN PROSTATE CARCINOMA", International journal of oncology, 6(1), 1995, pp. 209-213
10. YAGODA A; ABIRACHED B; PETRYLAK D
    CHEMOTHERAPY FOR ADVANCED RENAL-CELL CARCINOMA - 1983-1993
    Seminars in oncology
    
    A. Yagoda et al., "CHEMOTHERAPY FOR ADVANCED RENAL-CELL CARCINOMA - 1983-1993", Seminars in oncology, 22(1), 1995, pp. 42-60
11. YAGODA A; PETRYLAK D; THOMPSON S
    CYTOTOXIC CHEMOTHERAPY FOR ADVANCED RENAL-CELL CARCINOMA
    Urologic clinics of North America
    
    A. Yagoda et al., "CYTOTOXIC CHEMOTHERAPY FOR ADVANCED RENAL-CELL CARCINOMA", Urologic clinics of North America, 20(2), 1993, pp. 303-321